|Rapid Review Complete
|NovoRapid® FlexTouch ®
|For the treatment of diabetes mellitus in adults, adolescents and children aged 2 years and above.
|Rapid review commissioned
|Rapid review completed
|Rapid review outcome
|Full pharmacoeconomic assessment recommended at the submitted price.
The company has not submitted a HTA dossier to the NCPE therefore the cost effectiveness of the technology could not be proven.